PERDOCEO EDUCATION Corp 8-K
Research Summary
AI-generated summary
Perdoceo Education Approves 2026 Long‑Term Incentive Plan
What Happened
- Perdoceo Education Corporation held its annual meeting on May 21, 2026 and filed an 8‑K on May 27, 2026 announcing that stockholders approved the Perdoceo Education Corporation 2026 Long‑Term Incentive Plan (the "2026 Plan"). The 2026 Plan authorizes 4,500,000 shares for issuance, plus any shares recycled from awards under the company’s prior 2016 Plan.
- In connection with plan approval, the Compensation Committee approved forms of award agreements under the 2026 Plan: a restricted stock unit (RSU) agreement, a performance share unit (PSU) agreement, and an RSU agreement for non‑employee directors (filed as exhibits). The committee will set award amounts and terms in individual award agreements.
- At the same meeting, stockholders elected all nine director nominees and approved the advisory "say‑on‑pay" proposal and ratified Grant Thornton LLP as auditor for 2026.
Key Details
- 2026 Plan authorization: 4,500,000 shares, plus recycled shares from the 2016 Plan.
- Plan approval vote: 51,753,505 For; 2,443,873 Against; 14,331 Abstain; 4,273,446 Broker Non‑Votes.
- Advisory vote on executive compensation ("say on pay"): 53,091,201 For; 1,058,312 Against; 62,196 Abstain; 4,273,446 Broker Non‑Votes.
- Auditor ratification: Grant Thornton LLP ratified with 57,810,135 For; 671,429 Against; 3,591 Abstain. All nine director nominees were elected (vote totals reported in the 8‑K).
Why It Matters
- Approval of the 2026 Plan gives management the authority to grant equity awards (RSUs and PSUs) that can be used to recruit, retain and incentivize executives and directors. That may increase reported compensation expense and could dilute existing shareholders as awards vest and shares are issued.
- The Compensation Committee’s approved award forms set the framework for how future grants will be structured (performance‑based and restricted equity). Investors should watch future proxy disclosures and Form 8‑Ks for details on specific grants, vesting schedules, and potential dilution.
Loading document...